Study details
Enrolling now
A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change
Memorial Sloan Kettering Cancer Center
NCT IDNCT05010031ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
29
Study length
about 5.1 years
Ages
18+
Locations
7 sites in NJ, NY
What this study is about
This trial is testing whether reduced-dose radiotherapy can be an effective treatment for metastatic tumors with an ATM mutation. The researchers want to find the lowest dose of radiation that would still be effective to treat these tumors.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive Palliative radiotherapy
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Procedures
radiation